EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
163 hedge funds and large institutions have $509M invested in Eagle Pharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 72 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
+3
Holders Change %
+1.88%
% of All Funds
2.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
50
Reduced
72
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
$14M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
$11.1M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
$13.1M |
| 4 |
Morgan Stanley
New York
|
$9.43M |
| 5 |
State Street
Boston,
Massachusetts
|
$34.5M |
